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Background
Coronary magnetic resonance angiography (MRA) at 3T
suffers from imaging inconsistencies compared to 1.5T
despite the use of gadolinium-based contrast agents
(GBCAs). Gadofosveset Trisodium (Ablavar®, Lantheus
Medical Imaging), with its high relaxivity and long intra-
vascular residence time, offers greater potential over stan-
dard GBCAs to improve evaluation of the coronary
arteries. Compared to its validation in larger arteries, the
optimum dosage for coronary MRA has yet to be assessed.
The purpose of the study was to evaluate the diagnostic
potential of a 0.06 mmol/kg dose of Gadofosveset com-
pared to a standard clinical dose of 0.03 mmol/kg, using a
free-breathing whole-heart coronary MRA protocol with
1.0 mm3 spatial resolution and 100% navigator efficiency.
The injection protocol was optimized for the prolonged
pharmacokinetics of Gadofosveset.
Methods
Twenty two contrast enhanced CMR scans were per-
formed in 11 subjects [2 (18.2%) male; 27.3 ± 6 years; BMI
= 23.1 ± 3 kg/m2] on a 3.0T Verio Siemens scanner, using
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Figure 1 Data is presented as mean ± SD. CNRmyo: CNR between the blood and the myocardium. LMS: left main stem. LAD: left anterior
descending coronary artery. LCX: left circumflex coronary artery. RCA: right coronary artery. Desc. Aorta: descending Aorta. Prox. Aorta: proximal aorta
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an inversion-prepared spoiled gradient-echo sequence
(modified from Ref. [1]). The two scans were separated by
a 30-60 day interval, using dosages of either 0.06 mmol/kg
or 0.03 mmol/kg of Gadofosveset. Quantitatively, signal-
to-noise ratio (SNR) and contrast-to-noise ratios (CNR)
were measured. Qualitative AHA quality scores were eval-
uated [2]. Pairwise, Student’s t-test and Wilcoxon rank
test were performed for quantitative and qualitative assess-
ment (MedCalc Software v12.2.1, MariaKerke, Belgium).
Results
Overall, SNR and CNR was higher (p < 0.001) in the cor-
onary arteries for double- over single-dose of Gadofosveset
(24.18 ± 9.67 vs. 14.40 ± 5.0 and 14.27 ± 9.40 vs. 8.52 ±
4.01, respectively, Figure 1). Individual coronary arteries
demonstrated greater SNR enhancement for 0.06 mmol/kg
vs. 0.03 mmol/kg for the LMS (23.03 ± 7.45 vs. 12.37 ±
3.91, p < 0.001), LAD (26.12 ± 9.86 vs. 15.20 ± 3.88, p =
0.001), and RCA (29.54 ± 11.64 vs. 18.13 ± 6.29, p = 0.01).
CNR comparisons revealed similar results. Qualitatively,
similar number of main and branch vessels were identified
by two reviewers (Figure 2).
Conclusions
Quantitatively, a double dose of Gadofosveset shows
improvement in coronary arterial enhancement over
clinical dose. Ongoing research is aimed at evaluating the
diagnostic efficacy of a double-dose scanning regimen.
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